BridgeMD
Tests treatment safety and results for Burns
Official title Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
ClinicalTrials.gov ID: NCT01297400
What this study is testing
What is Investigational Drug, MW-III?
Investigational Drug, MW-III is an investigational medicine, given as a twice-daily treatment applied to the skin, being studied as a potential treatment for burns.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- To compare MW-III to Silvadene® Cream 1% (Silver Sulfadiazine) with respect to "time to healing" (≥95% re-epithelialization) of a partial thickness target thermal burn.
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adults, 18 years of age or older on the day of signing the informed consent.
- Thermal Burns not exceeding a total body surface area (TBSA) OF 25%, with at least one partial thickness burn of 0.5% TBSA or greater. If full...
- Able and willing to give informed consent and comply with study procedures.
You likely can't join if
- Any burn that at screening is:
- infected.
- circumferential or deemed, in the judgment of the investigator, at high risk for developing compartment syndrome.
- partial thickness that is likely, in the judgment of the Investigator, to require grafting within 72 hours, or other non-protocol intervention.
- Severe inhalation injury or other significant non-burn trauma.
The study team makes the final eligibility decision.
Where it's taking place
- Phoenix, Arizona, United States
- Sacramento, California, United States
- Washington D.C., District of Columbia, United States
- Iowa City, Iowa, United States
- Irapuato, Mexico
- Querétaro City, Mexico
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Phoenix, Arizona, United States; Sacramento, California, United States; Washington D.C., District of Columbia, United States; Iowa City, Iowa, United States; Irapuato, Mexico; Querétaro City, Mexico. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.